SLC5A2 and type 2 diabetes mellitus: demonstrated high sensitivity (0.94) for heart failure prediction using XGBoost on the All of Us dataset, particularly among type 2 diabetes patients on SGLT2 inhibitors, with key predictors including HbA1c and troponin [14].